Kolon Life Science Inc. (KOSDAQ:102940)
South Korea
· Delayed Price · Currency is KRW 53,500
-2,000 (-3.60%)
At close: Dec 5, 2025
Kolon Life Science Revenue
Kolon Life Science had revenue of 66.48B KRW in the quarter ending September 30, 2025, with 85.08% growth. This brings the company's revenue in the last twelve months to 211.13B, up 42.68% year-over-year. In the year 2024, Kolon Life Science had annual revenue of 161.39B with 29.48% growth.
Revenue (ttm)
211.13B
Revenue Growth
+42.68%
P/S Ratio
3.15
Revenue / Employee
496.78M
Employees
425
Market Cap
664.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 161.39B | 36.75B | 29.48% |
| Dec 31, 2023 | 124.64B | -36.94B | -22.86% |
| Dec 31, 2022 | 161.58B | -3.90B | -2.36% |
| Dec 31, 2021 | 165.49B | 36.07B | 27.87% |
| Dec 31, 2020 | 129.41B | -19.13B | -12.88% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Samsung Biologics | 5,504.84B |
| Hyundai Motor Company | 186.04T |
| Doosan Enerbility | 16.79T |
| KB Financial Group | 14.89T |
| HD Hyundai Heavy Industries | 16.39T |